|Market Research A to Z | Company Profiles A to Z | Register | Contact Us | Shopping Basket|
|+44 (0) 203 086 8600 Call us on|
The smart pill technology market has been forecast to increase at a compound annual growth rate (CAGR) of 17% over the next five years, to be worth a market value of $965 million by 2017.
Smart pill technology is used to diagnose gastrointestinal (GI) disorders such as constipation and gastroparesis. The technology functions by providing the practitioner with information pertaining to the GI tract such as pH, temperature and pressure. The technology comprises of a wireless capsule, a receiver worn by the patient and the computer software which analyses and sorts the information collated.
The rapid growth within the smart pill technology market is being fuelled by the rising number of screening treatments for gastrointestinal disorders as well as the improved reimbursement coverage across the developing and developed nations.
One company that hopes to take advantage of this is Buffalo, New York-based SmartPill Corp, which makes ingestible capsules for the diagnosis of GI disorders. Earlier this year, the company won reimbursement codes for its technology, and on Oct. 4 another capsule technology company, Given Imaging, bought the assets related to SmartPill GI Monitoring System for $6 million.
The best growth opportunities for the smart pill technology market lie within Asia-Pacific and Europe, whereas mature North American and West European markets are predicted to register modest growth.
In mature markets such as the US and Western Europe, growth looks set to be driven by a shift towards non- invasive devices by physicians and patients. Presence of high density population and growing healthcare awareness drives the smart pills market in Asia-Pacific and Middle-East region.
Key players dominating the smart pill technology market include, Given Imaging Limited (Israel), Medtronic, Inc (US), Olympus Corporation (Japan), Philips Research (Nethelands), Smart Pill, Inc (US), Medimetrics (US), and Novartis Pharma (Switzerland).
For more information on the smart pill technology market, see the latest research: Smart Pill Technology Market
Follow us on Twitter @CandMResearch
Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support
For the last month in 2014 we are offering discounted prices on a selection of new reports. Please contact us on 00 44 (0) 203 0868600 or via email (click here to email) to ask about prices and special discounts.
Available during December and the run-up to Christmas; Discounted prices on a selection of our reports.
We are offering our clients substantial savings on the best research available during December. Please contact us either via emailor by calling our team to discuss your specific research needs on Tel: 00 44 (0) 203 0868600. We look forward to being able to find you the research you require at good prices.